Ziqiang Yuan Selected Research

Ziqiang Yuan Research Topics

Disease

11	Neoplasms (Cancer) 06/2022 - 10/2009
6	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 12/2012
4	Infarction (Infarctions) 01/2021 - 01/2013
4	Carcinogenesis 03/2016 - 09/2004
3	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2007
3	Primitive Neuroectodermal Tumors (PNET) 01/2021 - 12/2012
3	Multiple Endocrine Neoplasia Type 1 01/2019 - 12/2012
3	Myocardial Infarction 05/2014 - 12/2012
2	Fibrosis (Cirrhosis) 01/2021 - 12/2019
2	Adenocarcinoma 01/2018 - 03/2007
2	Lung Neoplasms (Lung Cancer) 01/2018 - 03/2007
2	Retinoblastoma (Glioblastoma, Retinal) 03/2016 - 08/2007
2	Microsatellite Instability 10/2009 - 09/2003
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Infections 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2017
1	Starvation 03/2017
1	AIDS-Related Complex (ARC) 01/2015
1	Insulinoma 12/2012
1	Colonic Neoplasms (Colon Cancer) 10/2009
1	Breast Neoplasms (Breast Cancer) 04/2009
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2007
1	Adenocarcinoma of Lung 03/2007
1	Colorectal Neoplasms (Colorectal Cancer) 01/2006
1	Carcinoma (Carcinomatosis) 09/2004

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2006
4	Messenger RNA (mRNA)IBA 12/2019 - 10/2009
3	Insulin (Novolin)FDA Link 01/2021 - 03/2016
3	Therapeutic UsesIBA 01/2021 - 01/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 03/2016
2	Amino Acids FDA Link 06/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 06/2022 - 12/2012
2	ErbB Receptors (EGF Receptor)IBA 10/2009 - 08/2007
2	Complementary DNA (cDNA)IBA 04/2009 - 09/2003
1	Gemcitabine FDA Link 01/2022
1	AntigensIBA 01/2022
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2022
1	Granzymes (Granzyme)IBA 01/2022
1	PerforinIBA 01/2022
1	Hypoxia-Inducible Factor 1IBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	MicroRNAs (MicroRNA)IBA 12/2019
1	DNA (Cytosine-5-)-Methyltransferase 1IBA 01/2019
1	Cell-Free Nucleic AcidsIBA 01/2018
1	hydrogen sulfite (bisulfite)IBA 01/2018
1	Phosphorus (Red Phosphorus)IBA 03/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2017
1	Carrier Proteins (Binding Protein)IBA 03/2016
1	1-(1-mercaptocyclohexaneacetic acid)-2-(O- methyl-L-tyrosine)-8-L-arginine- vasopressin (AAVP)IBA 03/2016
1	LigandsIBA 03/2016
1	Peptides (Polypeptides)IBA 03/2016
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2016
1	Octreotide (Sandostatin)FDA LinkGeneric 03/2016
1	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2016
1	Protons (Proton)IBA 11/2015
1	Choline (Choline Chloride)IBA 11/2015
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2012
1	pasireotideIBA 12/2012
1	elisidepsinIBA 08/2011
1	Adenosine (Adenocard)FDA LinkGeneric 10/2009
1	Biomarkers (Surrogate Marker)IBA 04/2009
1	ChemokinesIBA 04/2009
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 08/2007
1	Tyrosine Kinase InhibitorsIBA 08/2007
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2007
1	Cyclin-Dependent Kinase Inhibitor p27IBA 08/2007
1	CyclinsIBA 08/2007
1	Cyclin EIBA 03/2007
1	CopperIBA 01/2006
1	Cyclin D1IBA 09/2004
1	AsbestosIBA 09/2004
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2004

Therapy/Procedure

2	Transplantation 05/2014 - 01/2013
1	Immunotherapy 01/2022
1	Aftercare (After-Treatment) 01/2022
1	Ligation 01/2021
1	Therapeutics 01/2019